INTRODUCTION
The lysosomal storage disorders (LSDs) are a family of human genetic diseases caused by the defective activity of lysosomal proteins (1) . Many of these disorders are characterized by severe neurological impairment (2). Of this family of ~40 disorders, Gaucher disease (GD) is the most common (3), although only a relatively small sub-set of GD patients suffer from neurological disease (4). The acute neuronopathic form of GD is characterized by severe neuronal loss (5) and by astrogliosis (6), but little information is available to delineate the biochemical pathways leading from glucosylceramide (GlcCer) accumulation to neuronal death or dysfunction (1, 7) .
One pathway which is involved in the pathology of a number of LSDs is altered calcium homeostasis (8). In the case of neuronopathic Gaucher disease (nGD), enhanced agonist-induced calcium release via the ryanodine receptor has been detected in both neuronal culture models (9) and in human brain tissue (10). This results in depletion of endoplasmic reticulum (ER) calcium stores, which could in turn lead to ER stress and activation of the unfolded protein response (UPR) (11) . The UPR prevents accumulation of unfolded proteins in the ER by decreasing the protein-folding load, increasing the ER protein-folding capacity, and increasing degradation of mis-folded proteins through ER-associated protein degradation or through autophagy (12) (13) (14) ; however, if ER stress is too massive, the UPR will eventually lead to cell death.
UPR activation has been observed in several neurodegenerative diseases such as
Alzheimer's and Parkinson's diseases (15) , as well as in two neurodegenerative LSDs, GM1 gangliosidosis (16) and infantile neuronal ceroid lipofuscinoses (INCL) (17) . In addition, UPR activation was demonstrated in fibroblasts derived from nGD patients and was suggested to be a common mediator for apoptosis in neurodegenerative LSDs (18).
4
To determine the possible role of the UPR in nGD, we have examined UPR activation in both neuronal culture models of nGD and in neuronal tissues obtained from mouse models of nGD. We did not obtain any evidence for UPR activation and therefore suggest that recent assumptions (18) that the UPR is a common mediator of apoptosis in neurodegenerative LSDs needs to be re-assessed. 
RESULTS

UPR in Gaucher neurons and astrocytes
We previously demonstrated that incubation of cultured hippocampal neurons for 4-9 days with 200 µM conduritol B-epoxide (CBE), an active-site directed inhibitor of glucocerebrosidase (GlcCerase) (19, 20) , results in an ~5-fold increase in intracellular GlcCer levels (9) with no effect on neuronal viability (9). To determine whether the UPR is activated in this nGD model, we examined changes in levels of a number of proteins typically used to indicate activation of the UPR; thus, BiP is an ER chaperone and a regulator of the UPR (21, 22), CHOP is a transcription factor which mediates ER stress-induced apoptosis (23), and XBP1 is a potent UPR transcription factor that is spliced by removal of a short intron from its mRNA upon UPR activation (24). No changes were observed by western blot analyses of BiP in neurons incubated with CBE concentrations as high as 600 µM (Fig. 1A) . Similarly, no changes were observed by RT-PCR in mRNA levels of BiP, CHOP or XBP1 after 5 (Fig. 1B) , 8 or 15 (not shown) days of CBE-treatment (200 µM), and no XBP1 mRNA splicing was detected (Fig. 1B) .
In addition, we systematically examined mRNA levels by quantitative real-time RT-PCR (qPCR) after 8 days of CBE treatment, including analyses of GRP58, a chaperone involved in glycoprotein folding, and Herp (HERPUD1), a ubiquitin-like membrane protein, both of which are induced by ER stress (21, 25) . No changes were observed in mRNA levels of BiP, CHOP, Herp or GRP58 (Fig 1C) .
The lack of UPR activation might be consistent with the normal viability of CBE-treated neurons. Indeed, early studies suggested that neuronal viability is not affected for at least 15 days incubation with CBE (26); however, CBE-treated neurons did show pronounced changes in axonal (26) (but not dendritic (27)) branching. Later studies showed significant changes in agonist-induced calcium release in CBE-treated neurons, although basal levels of calciumrelease were normal (9). We therefore examined whether the UPR was induced in nGD neurons upon disruption of calcium homeostasis. Rat hippocampal neurons were incubated with thapsigargin, which depletes ER calcium stores (28), and as a result leads to UPR activation and apoptosis (11, 29) . No differences were observed in neuronal death between control and CBEtreated neurons (6 days) after thapsigargin treatment (76.7% dead cells in control neurons and 69.3% dead cells in CBE-treated neurons after 2 hours incubation with 7 µM thapsigargin, and 25.9% and 26.6% dead cells respectively using 8 µM thapsigargin). These results imply that there is no difference in the response of CBE-treated compared to control neurons to an inducer of ER stress, strongly suggesting that the UPR is not altered in this neuronal model of nGD even under conditions of ER stress.
A recent study demonstrated glial pathology in neuronal forms of GD (6). We therefore examined whether the UPR is induced in astrocytes, glial cells which play an active role in brain function and in neurodegenerative diseases (30, 31). Cultured astrocytes were incubated with [4,5- 3 H]sphinganine, a precursor of sphingolipid synthesis, which can be used to metabolically label glycosphingolipids including GlcCer (32). Significant [ 3 H]GlcCer accumulation was observed ( Fig. 2A) after CBE-treatment (200 µM, 5 days), and no changes were observed in astrocyte viability (Fig. 2B ). BiP protein levels were unchanged (Fig. 3A) , as were mRNA levels of BiP, CHOP, and XBP1 ( Fig. 3B ,C), Herp and GRP58 (Fig. 3C) . The above findings do not lend support to the notion that the UPR is activated in cultured nGD neurons or glia.
UPR in Gaucher brain
Within the past year, a mouse model of nGD has become available (33). In the Gba flox/flox ;Nestin-Cre mouse (hereafter referred to as the Nestin-flox -/-mouse), GlcCerase 7 deficiency is restricted to neural and glial progenitor cells, and the mice exhibit rapid motor dysfunction associated with severe neurodegeneration and apoptotic cell death, and develop paralysis by 21 days of age (33). We examined UPR activation at two different stages of development, the presymptomatic (9 days) and symptomatic stages (21 days). Western blot analyses revealed that levels of BiP were unaltered in the cortex (Fig. 4A ) at both of these stages, and also unaltered in the cerebellum and hippocampus after 21 days (not shown). RT-PCR revealed no changes in XBP1 levels or in XBP1 splicing in the cerebellum (Fig. 4B) , cortex, brain stem and thalamus (not shown). We next performed an extensive qPCR analysis of mRNA levels of BiP, GRP58, Herp and CHOP in five different brain areas of 9 day-and 21 day-old mice. No changes were observed in mRNA levels in the first three markers (Table 1) . In some cases, levels of CHOP were elevated to a limited extent of between 1.42-1.90-fold, but these changes only occurred in some brain areas and were not consistent between the different mice examined (Table 1) . Moreover, CHOP can be induced upon elevation of cytosolic calcium levels in a UPR-independent manner (34).
Finally, we examined whether the UPR is altered in two other mouse models of nGD, the Gba mouse (35) and the L444P mouse (36) . The Gba mouse dies soon after birth due to skin permeability dysfunction (37) . No changes were observed in BiP, CHOP and XBP1 levels in either the cortex from day 18 embryonic Gba mice or in hippocampal neurons cultured from day 18 embryos (not shown). The L444P mouse, which carries a mutation that most commonly leads to nGD, does not accumulate significant levels of GlcCer (36), and does not exhibit changes in UPR markers (BiP, CHOP and XBP1) in brain regions of 3 month-old mice (as determined by western blot analysis of BiP in the cortex, hippocampus, thalamus, cerebellum and brain stem, not shown) or in cultured neurons from embryonic mice (as determined by RT-PCR of BiP,
DISCUSSION
The major finding of the current study is that we find no evidence for UPR activation in various models of nGD. This result is somewhat unexpected since a recent report by Wei et al (18) suggested that the UPR is activated in nGD, and furthermore proposed that the UPR is a common mediator of apoptosis in both neurodegenerative and non-neurodegenerative LSDs.
Indeed, other studies demonstrated UPR activation in two neurodegenerative LSDs, the GM1 gangliosidosis (16) and INCL (17, 38, 39) (Table 2 ).
There are two noteworthy differences between the study by Wei et al. (18) and the current study. First, in the study by Wei et al., ER stress and the UPR were examined in human skin fibroblast cell lines derived from patients characterized with type 2 (the acute neuronopathic form) nGD, whereas in our study, primary tissues obtained from neuronal models of nGD were used including cultured neurons and glia and also tissues from mouse models of nGD. The use of neuronal cells and brain tissues is of more relevance for understanding which biochemical pathways are triggered in a neurological disease than skin fibroblast cell lines, particularly in light of the altered calcium homeostasis observed in the neuronal nGD models (9, 10, 40, 41), as a result of GlcCer accumulation (40) which could potentially lead to UPR activation (11, 14) .
Secondly, there is no evidence that fibroblasts accumulate significant levels of storage materials in LSDs. This is particularly relevant for diseases such as the gangliosidoses, since gangliosides are not found at high levels in non-neuronal tissues, and evidence for UPR activation in fibroblasts derived from GM1 and GM2 gangliosidoses patients (18) is therefore unlikely to be the result of ganglioside storage. Likewise, in order to conclude that GlcCer storage is the cause of UPR activation in the Gaucher skin fibroblast cell lines, significant levels of accumulation, such as those shown in neuronal cells, need to be demonstrated.
MATERIALS AND METHODS
Materials
CBE was from Matreya and thapsigargin was from Sigma.
Hippocampal cultures
Hippocampal neurons were cultured from embryonic day 16-17 mice (C57BL/6J, Gba (35, 42) or L444P (36) mice) or from embryonic day 17-18 Wistar rats (Harlan) essentially as described (26, 42, 43) , except that neurons were cultured in Neurobasal medium containing B27 supplement (Gibco) and Glutamax. To prevent proliferation of non-neuronal cells, 5 µM of cytosine arabinoside (Sigma) was added 2-3 days after plating.
Glial cultures
Cortices from postnatal day 0-2 ICR mice (Harlan) were dissociated by trypsinization Cell pellets were either used immediately for RNA or protein extraction, or snap frozen in liquid N 2 and stored at -80°C.
Nestin-flox/flox mice
Flox/flox Cre-/-females were crossed with wild type/flox Cre+/-males to generate flox/flox Cre+/-mice (the Nestin-flox -/-Gaucher mouse) and wild type/flox Cre+/-mice, which served as healthy controls. Genotyping was performed by PCR using genomic DNA extracted from mouse tails or embryonic brains as previously described (33). For characterization of the Gba allele, primer 1 (forward: 5'-GTACGTTCATGGCATTGCTGTTCACT-3') and primer 2 (forward: 5'-ATTCCAGCTGTCCCTCGTCTCC-3') were used. A 1.9 kb fragment was generated from the wild type allele, a 2.1 kb fragment from the floxed allele, and a 0.7 kb fragment from the null allele. For detection of Cre, the following primers were used: forward: 5'-ACGAGTGATGAGGTTCGCAA-3'; reverse: 5'-AGCGTTTTCGTTCTGCCAAT-3', which generated a 600 bp fragment in the Cre+ mice. The colony was maintained in the Experimental Animal Center of the Weizmann Institute.
RNA extraction and PCR
Total RNA was isolated using the RNeasy mini kit (Qiagen) according to manufacturer's instructions, which included a DNAse step and addition of ß-mercaptoethanol. cDNA synthesis was performed using the Reverse-iT first strand synthesis kit (Thermo Scientific) using random decamers. cDNA products were stored at -20°C.
Semi-quantitative RT-PCR was performed using Taq DNA Polymerase master mix red (Genetec), with cDNA (amount equivalent to 2.5 ng of total RNA), and primer concentrations of 2 nM, in a reaction volume of 25 μl. All reactions were performed in duplicate. The thermal cycling parameters were as follows: step 1, 94°C for 4 mins; step 2, 94°C for 30 sec, 60°C for 30 sec, 72°C for 50 sec.
Step 2 was repeated for 22-30 cycles. PCR products were separated by electrophoresis on a 1.5%-2% agarose gel, except for XBP1 PCR products, which were separated on a 3% agarose gel. GAPDH or HPRT served as reference genes. Primer sequences are given in Table 3 .
Real-time quantitative RT-PCR (qPCR) was performed using the SYBR Green PCR Master Mix (Finnzyme), and an ABI Prism 7000 Sequence Detection System (Applied Biosystems) with cDNA (equivalent to 8.75 ng of total RNA for CHOP analysis and 2.5 ng for the other genes). The primer concentration was 13 nM in a reaction volume of 20 μl. Each reaction was preformed in triplicate. The thermal cycling parameters were as follows: step 1, 95°C for 10 min; step 2, 95°C for 15 sec, 60°C for 30 sec and 68°C for 30 sec.
Step 2 was repeated for 40 cycles and was followed by a dissociation step. The relative amounts of mRNA were calculated from the CT values using HPRT or TBP for normalization. Normalization quality was assessed using geNorm software with respect to the reference genes HPRT, actin and TBP. The standard error of the ratio was estimated using the bootstrap method (44) in the R statistical package (45) . Primer sequences are listed in Table 3 .
Western blotting
Brain tissue or cells pellets were lysed in ~6 volumes of RIPA buffer (50 mM Tris pH 
